CoreCivic Q3 EPS $14.49 on $1.8B Facility Gain; Board Adds $500M to Buyback
CXW sits 92% above its 52-week low of $15.735.
Summary
CoreCivic reported Q3 2026 net income of $1.34 billion ($14.49 per diluted share) on a $1.77 billion gain from selling four facilities to DHS, while Adjusted EPS doubled to $0.49. The board added $500 million to the share repurchase program, bringing total authorization to $1.7 billion with about $755.8 million remaining.
Key Events · Earnings and Guidance · CXW
-
Q3 Results Boosted by Facility Sales
Total revenue rose 28.2% to $744.1 million and net income reached $1,344.1 million, or $14.49 per diluted share, driven by a $1,770.7 million net gain on the sale of four detention facilities to DHS for $2.2 billion gross.
-
Operating Earnings Improve Sharply
Excluding the gain and other special items, Adjusted Diluted EPS doubled to $0.49 from $0.24 and Adjusted EBITDA rose 32.6% to $117.8 million, helped by occupancy of 84.0% versus 76.7% a year earlier.
-
Buyback Authorization Raised by $500M
The board authorized an additional $500.0 million on November 3, 2026, lifting the program from $1.2 billion to $1.7 billion; approximately $755.8 million remains available before any further ASR settlement.
-
Balance Sheet Deleveraged After Asset Sale
CoreCivic applied $1.6 billion of after-tax proceeds to repay over $700 million of debt and fund a $500 million accelerated share repurchase, reducing net debt to Adjusted EBITDA to (0.1)x from 2.5x.
Analysis · CXW · Real Estate & Construction
CoreCivic's third quarter was dominated by the $2.2 billion sale of four detention facilities to the Department of Homeland Security, which produced a $1.77 billion net gain and turned reported net income into $1.34 billion, or $14.49 per diluted share. Strip that out and the operating business still improved: Adjusted Diluted EPS rose 104% to $0.49 and Adjusted EBITDA rose 32.6% to $117.8 million on higher ICE occupancy and the Clinical Solutions Pharmacy acquisition. The company used $1.6 billion of after-tax proceeds to repay over $700 million of debt and fund a $500 million accelerated share repurchase, cutting net debt to Adjusted EBITDA to (0.1)x from 2.5x. The board then added another $500 million to the buyback on November 3, leaving roughly $755.8 million available. Guidance was mixed: Adjusted Diluted EPS and Adjusted EBITDA ranges were raised, but GAAP net income was trimmed, largely reflecting the facility-sale gain already booked.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CXW was trading at $30.20 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3B. The 52-week trading range was $15.74 to $36.55. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.